Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | HRH1 | P35367 | 1/20 | 0.60 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | GFER | P55789 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.56 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1331974 | 1.00 | CYP1A2 (0.71) | CYP1A2CYP2C19KMT2AKDM4EALDH1A1 | |
| SCHEMBL20804356 | 1.00 | CYP1A2 (0.71) | CYP1A2CYP2C19KMT2AKDM4EALDH1A1 | |
| SCHEMBL30141847 | 1.00 | CYP1A2 (0.71) | CYP1A2CYP2C19KMT2AKDM4EALDH1A1 | |
| SCHEMBL1333260 | 1.00 | CYP1A2 (0.71) | CYP1A2CYP2C19KMT2AKDM4EALDH1A1 | |
| SCHEMBL8634159 | 0.94 | CYP1A2 (0.65) | CYP1A2CYP2C19KMT2AKDM4EALDH1A1 | |
| SCHEMBL1822554 | 0.92 | CYP1A2 (0.67) | CYP1A2CYP2C19KMT2AKDM4EALDH1A1 | |
| SCHEMBL31106560 | 0.92 | CYP1A2 (0.67) | CYP1A2CYP2C19KMT2AKDM4EALDH1A1 | |
| SCHEMBL18301469 | 0.91 | CYP1A2 (0.66) | CYP1A2CYP2C19KMT2AKDM4EALDH1A1 | |
| SCHEMBL1331614 | 0.91 | CYP1A2 (0.66) | CYP1A2CYP2C19KMT2AKDM4EALDH1A1 | |
| SCHEMBL6269839 | 0.91 | CYP1A2 (0.66) | CYP1A2CYP2C19KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4610269-A1 | UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE | 3B Pharmaceuticals GmbH (DE) | 2025-09-03 | — | — | EP | disclosed |
| CN-120129534-A | Radiopharmaceutical composition | 日本医事物理股份有限公司 | 2025-06-10 | — | — | CN | disclosed |
| US-20250059379-A1 | PAINTS CONTAINING DRIERS BASED ON VANADIUM COMPOUNDS BEARING VARIOUS ACID ANIONS | BORCHERS GMBH (DE) | 2025-02-20 | — | — | US | disclosed |
| US-20240417590-A1 | PROCESS FOR IMPROVING RESIN PERFORMANCE USING LEWIS ACIDS | BORCHERS GMBH (DE) | 2024-12-19 | — | — | US | disclosed |
| US-20240368378-A1 | PROCESS FOR IMPROVING RESIN PERFORMANCE | BORCHERS GMBH (DE) | 2024-11-07 | — | — | US | disclosed |
| EP-4453106-A1 | PAINTS CONTAINING DRIERS BASED ON VANADIUM COMPOUNDS BEARING VARIOUS ACID ANIONS | Borchers GmbH (DE) | 2024-10-30 | — | — | EP | disclosed |
| US-20240316228-A1 | RADIOACTIVE COMPLEX OF DEGLYCOSYLATED ANTIBODY AND RADIOACTIVE PHARMACEUTICAL PRODUCT | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2024-09-26 | — | — | US | disclosed |
| CN-118647679-A | Coating containing a drier based on vanadium compounds with various acid anions | 博奇斯有限公司 | 2024-09-13 | — | — | CN | disclosed |
| EP-4408942-A1 | PROCESS FOR IMPROVING RESIN PERFORMANCE USING LEWIS ACIDS | Borchers GmbH (DE) | 2024-08-07 | — | — | EP | disclosed |
| CN-118382464-A | Stabilized radiopharmaceutical compositions | 日本医事物理股份有限公司 | 2024-07-23 | — | — | CN | disclosed |
| WO-2023117421-A1 | PAINTS CONTAINING DRIERS BASED ON VANADIUM COMPOUNDS BEARING VARIOUS ACID ANIONS | BORCHERS GMBH (DE) | 2023-06-29 | — | — | WO | disclosed |
| US-20230203336-A1 | Paints Containing Driers Based on Vanadium Compounds Bearing Anions of Sulfonic Acids as Counter Ions | BORCHERS GMBH (DE) | 2023-06-29 | — | — | US | disclosed |
| EP-4172283-A1 | PAINTS CONTAINING DRIERS BASED ON VANADIUM COMPOUNDS BEARING ANIONS OF SULFONIC ACIDS AS COUNTER IONS | Borchers GmbH (DE) | 2023-05-03 | — | — | EP | disclosed |
| WO-2023052294-A1 | PROCESS FOR IMPROVING RESIN PERFORMANCE USING LEWIS ACIDS | BORCHERS GMBH (DE) | 2023-04-06 | — | — | WO | disclosed |
| WO-2023030700-A1 | PROCESS FOR IMPROVING RESIN PERFORMANCE | BORCHERS GMBH (DE) | 2023-03-09 | — | — | WO | disclosed |
| WO-2023033022-A1 | RADIOACTIVE COMPLEX OF DEGLYCOSYLATED ANTIBODY AND RADIOACTIVE PHARMACEUTICAL PRODUCT | 日本メジフィジックス株式会社 | 2023-03-09 | — | — | WO | disclosed |
| CN-115720590-A | Paint comprising a drier based on a vanadium compound containing a sulphonic anion as a counterion | 博奇斯有限公司 | 2023-02-28 | — | — | CN | disclosed |
| US-11518834-B2 | Radically polymerizable compositions | Polynt Composites USA, Inc. (US) | 2022-12-06 | — | — | US | disclosed |
| WO-2022224980-A1 | RADIOACTIVE COMPLEX OF ANTI-CD20 ANTIBODY, AND RADIOPHARMACEUTICAL | 日本メジフィジックス株式会社 | 2022-10-27 | — | — | WO | disclosed |
| WO-2022211051-A1 | RADIOACTIVE COMPLEX OF ANTI-EGFR ANTIBODY, AND RADIOPHARMACEUTICAL | 日本メジフィジックス株式会社 | 2022-10-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240316228-A1 | RADIOACTIVE COMPLEX OF DEGLYCOSYLATED ANTIBODY AND RADIOACTIVE PHARMACEUTICAL PRODUCT | FCGR2A, FCGR1A, FCGR3B | CYP1A2 3044/4885CYP2C19 2169/4885KMT2A 2420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.